Barclays advice for Teva Pharmaceuticals
| Date | Bank | Stock | Advice | Price | Difference |
|---|---|---|---|---|---|
| January 31, 2017 | Barclays | Teva Pharmaceuticals | Hold | 38.00 USD | 76.50 % |
Advice details
Glasgow - Op 31 Jan 2017 verlagen de analisten hun advies voor the American pharmaceutical company Teva Pharmaceuticals (ISIN: US8816242098 / Mnemo: TEVA) van Kopen naar Houden. Het 12-maands koersdoel wordt neerwaarts bijgesteld van 65.0 USD naar 38.0 USD.
Back
| About us | Network | Partners |
| Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos |
Analist.nlLinksISIN
|
MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-x
|
©2025 ValueSpectrum. All Rights Reserved
Developed and maintained by 